United Services Automobile Association Invests $472,000 in Doximity, Inc. $DOCS

Key Points

• United Services Automobile Association acquired 8,070 shares of Doximity, Inc. valued at approximately $472,000 during the first quarter, indicating increased interest from institutional investors.
• Doximity's stock reported a 0.7% decline, with its current price at $69.01, while the company has a market capitalization of $12.92 billion.
• The company recently reported earnings per share (EPS) of $0.36 for the last quarter, surpassing analyst expectations and reflecting a 15.2% year-over-year revenue increase.

United Services Automobile Association bought a new position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 8,070 shares of the company's stock, valued at approximately $472,000.

Other large investors have also recently made changes to their positions in the company. VSM Wealth Advisory LLC purchased a new position in shares of Doximity in the 1st quarter worth approximately $29,000. Allworth Financial LP raised its holdings in shares of Doximity by 104.0% in the 1st quarter. Allworth Financial LP now owns 563 shares of the company's stock valued at $32,000 after purchasing an additional 287 shares in the last quarter. National Bank of Canada FI purchased a new stake in Doximity during the first quarter worth $33,000. Spire Wealth Management boosted its position in Doximity by 73.2% during the first quarter. Spire Wealth Management now owns 615 shares of the company's stock valued at $36,000 after purchasing an additional 260 shares in the last quarter. Finally, Brooklyn Investment Group grew its position in shares of Doximity by 70.7% in the 1st quarter. Brooklyn Investment Group now owns 746 shares of the company's stock worth $43,000 after buying an additional 309 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors.

Doximity Price Performance

DOCS traded up $0.79 during trading on Friday, reaching $71.05. 1,374,597 shares of the company's stock were exchanged, compared to its average volume of 2,224,099. Doximity, Inc. has a 1 year low of $38.30 and a 1 year high of $85.21. The stock has a market capitalization of $13.31 billion, a P/E ratio of 71.05, a price-to-earnings-growth ratio of 4.10 and a beta of 1.37. The company's fifty day simple moving average is $63.60 and its 200-day simple moving average is $59.83.

Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same period in the prior year, the company posted $0.28 EPS. Doximity's revenue was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Equities analysts forecast that Doximity, Inc. will post 0.99 EPS for the current year.

Insiders Place Their Bets

In related news, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the completion of the transaction, the director directly owned 16,618 shares in the company, valued at approximately $948,721.62. This trade represents a 10.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Timothy S. Cabral sold 10,000 shares of the business's stock in a transaction that occurred on Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total value of $600,000.00. Following the completion of the transaction, the director directly owned 6,360 shares of the company's stock, valued at $381,600. The trade was a 61.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 32,000 shares of company stock valued at $1,929,380. Company insiders own 31.30% of the company's stock.

Wall Street Analyst Weigh In

DOCS has been the subject of several recent analyst reports. KeyCorp raised their target price on shares of Doximity from $65.00 to $70.00 and gave the company an "overweight" rating in a research note on Monday, July 14th. Needham & Company LLC boosted their target price on Doximity from $67.00 to $75.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. Zacks Research cut Doximity from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 20th. Wells Fargo & Company raised their price target on Doximity from $55.00 to $62.00 and gave the stock an "equal weight" rating in a report on Monday, August 4th. Finally, Mizuho cut their price objective on shares of Doximity from $65.00 to $60.00 and set a "neutral" rating on the stock in a report on Friday, May 16th. Two research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and eleven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $67.00.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.